Research Article
Integrated Analyses of the Expression and Prognostic Value of EPHB6 in Cervical Cancer and Its Correlation with Immune Infiltrates
Table 2
Univariate and multivariate analyses on the overall survival based on the cox regression model.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Age | 306 | | | | | ≤50 | 188 | Reference | | | | >50 | 118 | 1.289 (0.810–2.050) | 0.284 | | | Clinical stage | 299 | | | | | Stage I and Stage II | 231 | Reference | | | | Stage III and Stage IV | 68 | 2.369 (1.457–3.854) | <0.001 | 2.529 (1.551–4.123) | <0.001 | Histologic grade | 274 | | | | | G1 and G2 | 154 | Reference | | | | G3 and G4 | 120 | 0.866 (0.514–1.459) | 0.589 | | | EPHB6 | 306 | | | | | Low | 153 | Reference | | | | High | 153 | 0.439 (0.272–0.709) | <0.001 | 0.420 (0.259–0.680) | <0.001 |
|
|
The bold values mean statistically significant.
|